Evogen's Cognizance Biomarkers Presents Data Showing Its Proteomic Biomarkers Have the Potential to Monitor Seizure Burden to Aid in Epilepsy Patient Management
Advertisement
--Data Presented at 2019 Antiepileptic Drug and Device Trials XV Conference Supports Further Development of a Blood-Based Test to Accurately Monitor Seizure Burden--